In this prospective cohort study, the researchers observed an association between maternal depressive symptoms during pregnancy with slower rates of fetal growth.
Dr. Marlene Freeman recently shared her insights on Psychiatric Medications and Considerations for Individuals Across Pregnancy, the Postpartum, and Reproductive Years with the National Alliance on Mental Illness on March 7, 2024.
Women who experienced depression during pregnancy were about four times as likely to experience PPD compared to women with no depression during pregnancy, with greater risk associated with depression during the first and third trimesters.
To better care for pregnant and postpartum mothers with ADHD, clinicians should understand the unique facets of ADHD in women, how symptoms change during pregnancy and the postpartum period, and how to help new parents make decisions around medication use and ADHD symptom management.
At 7 years of age, children exposed to maternal depression during pregnancy or SSRI antidepressants exhibited similar changes in white matter architecture.
A wide range of delivery options may be effective for addressing symptoms of depression in perinatal individuals, and could therefore be leveraged to expand access to treatments.
Compared to individuals with histories of psychiatric illness prior to pregnancy, perinatal individuals without a prepregnancy psychiatric history were less likely to be screened, referred, and treated for depression.
Psychological interventions may reduce the severity of perinatal anxiety symptoms.
There is evidence that screening for perinatal mood and anxiety disorders may improve outcomes; however, success depends on adequate resources for screening, diagnosis, treatment and follow-up.
 Some good news from our colleagues at the Maternal Mental Health Leadership Alliance (MMHLA)... The United States Department of Health and Human Services (HHS) is planning to launch significant initiatives addressing the maternal mental [...]
